Pharmadrug Inc.

OTC: LMLLF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH 24DQ —GM —SS 33

v0.1 · 35/100 weight · pillars only

↑ disclosure history, listing tenure · ↓ balance-sheet leverage, Altman-Z

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$274.0k

Employees

Market cap

$547.7k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$274.0k-383.1k CAD2025

Operating income-$161.5k-225.7k CAD2025

Total assets$402.2k551.2k CAD2025

Liabilities$1.6M2.2M CAD2025

Equity-$1.3M-1.8M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

$460.1k

FY19

$509.7k

FY20

$5.6k

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Pharmadrug Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

MC Endeavors, Inc.——One World Products, Inc.——Aethlon Medical, Inc.43D Tivic Health Systems, Inc.34D

Key facts

CEODavid Kideckel

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: LMLLF

Employees9

IPO date2017-05-19

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.